Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer Academic Article Article uri icon

Overview

MeSH Major

  • Bulimia Nervosa
  • Estrogens
  • Serotonin

abstract

  • Although the diagnosis of a tobacco-related malignancy clearly represents a strong catalyst for smoking cessation, a sizable subgroup of patients continue to smoke. Patients with less severe disease who undergo less extensive treatment are particularly at risk for continued tobacco use. These data highlight the importance of developing smoking cessation interventions designed to meet the demographic, disease, treatment, and tobacco-use characteristics of this patient population.

publication date

  • January 1995

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(19950115)75:2<569::AID-CNCR2820750221>3.0.CO;2-I

PubMed ID

  • 7812925

Additional Document Info

start page

  • 569

end page

  • 76

volume

  • 75

number

  • 2